TB
Tia L Bush (Chief Technology & Quality Ofc) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $1.1M of CNTA (40,000 sh × $28.00, as filed), executed Nov 17 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 17 2025
Filed Nov 18 2025
Median ADV $76.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CNTA
Centessa Pharmaceuticals plc
CNTA · 0 buys · 6 sells
6 filings
Recent filings
CNTASALE
Centessa Pharmaceuticals plc
View filing →
$1.1M40,000 sh × $28.00
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $1.0M
40,000 sh × $26.00
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $840K
35,000 sh × $24.00
Exec Sep 24 2025
Filed Sep 24 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $1.0M
49,792 sh across 2 lots
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $185K
11,000 sh × $16.86
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $478K
27,424 sh across 2 lots
Exec Dec 16 2024
Filed Dec 17 2024 · 5:30 PM ET